Welcome To ImmuneBiotech

 

ImmuneBiotech is aimed to be a research and development company dedicated to find new ways to promote better health for patients with autoimmune disorders e.g. Multiple Sclerosis, Rheumatoid Arthritis and Type 1 Diabetes through pharmaceutical probiotic innovations. Considering the increased interest in bacterial food supplements, called probiotics, as potent inducers of anti-inflammatory responses and modulators of intestinal barrier integrity, we have developed a quite unique approach to treat autoimmune disorders by manipulating/stimulating the gut flora via oral administration of excessive lactobacilli with probiotic properties. The company aims to develop new and powerful therapeutic protocols, bacterial combinations or technologies for sale or royalty financing agreements.

 

As a part of the financing strategies ImmuneBiotech (RTCE) provides contract research services for Biotech and Pharmaceutical companies and even for academic groups at the universities. The company offers a broad range of services within the area of immunology, cancer, inflammatory disorders, functional food, and drug discovery. It consist of a highly experienced team devoted to performing services within a short span of time and delivering results with the highest achievable quality standards.